{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Clerkin KJ"],"funding":["National Heart, Lung, and Blood Institute","NHLBI NIH HHS"],"pagination":["12-23"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8724562"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10(1)"],"pubmed_abstract":["<h4>Objectives</h4>This analysis sought to investigate the waitlist and post-transplant outcomes of individuals bridged to transplantation by using temporary percutaneous endovascular mechanical circulatory support (tMCS) through a status 2 designation (cardiogenic shock and exception).<h4>Background</h4>The 2018 donor heart allocation policy change granted a status 2 designation to patients supported with tMCS.<h4>Methods</h4>Adult patients in the United Network for Organ Sharing registry after October 18, 2018 who received a status 2 designation for tMCS were included and grouped by their status 2 criteria: cardiogenic shock with hemodynamic criteria (CS-HD), cardiogenic shock without hemodynamic criteria before tMCS (CS-woHD), and exception. Baseline characteristics, waitlist events (de"],"journal":["JACC. Heart failure"],"pubmed_title":["Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System."],"pmcid":["PMC8724562"],"funding_grant_id":["K23 HL148528"],"pubmed_authors":["Clerkin KJ","Jain R","Salako O","Colombo PC","Topkara VK","Farr MA","Uriel N","Restaino S","Griffin JM","Fried JA","Takeda K","Sayer G","Raikhelkar J"],"additional_accession":[]},"is_claimable":false,"name":"Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System.","description":"<h4>Objectives</h4>This analysis sought to investigate the waitlist and post-transplant outcomes of individuals bridged to transplantation by using temporary percutaneous endovascular mechanical circulatory support (tMCS) through a status 2 designation (cardiogenic shock and exception).<h4>Background</h4>The 2018 donor heart allocation policy change granted a status 2 designation to patients supported with tMCS.<h4>Methods</h4>Adult patients in the United Network for Organ Sharing registry after October 18, 2018 who received a status 2 designation for tMCS were included and grouped by their status 2 criteria: cardiogenic shock with hemodynamic criteria (CS-HD), cardiogenic shock without hemodynamic criteria before tMCS (CS-woHD), and exception. Baseline characteristics, waitlist events (de","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jan","modification":"2025-04-19T18:07:30.128Z","creation":"2025-04-19T18:07:30.128Z"},"accession":"S-EPMC8724562","cross_references":{"pubmed":["34969492"],"doi":["10.1016/j.jchf.2021.08.003"]}}